Seelos Therapeutics Announces Update to Parkinson’s Disease Program SLS-007

Go back to Seelos Therapeutics Announces Update to Parkinson’s Disease Program SLS-007
(NASDAQ: SEEL) Delayed: 1.28 --0 (-0%)
Previous Close $1.28    52 Week High
Open $1.28    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.28    EPS
Volume 75,677       

(NASDAQ: SEEL) Delayed: 1.28 --0 (-0%)
Previous Close $1.28    52 Week High
Open $1.28    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.28    EPS
Volume 75,677